Logo
RadAI Slice
Subscribe
Sort by:
Page 1 of 5 • 45 results
Next

Deep Learning Enables Large-Scale Shape and Appearance Modeling in Total-Body DXA Imaging

Arianna Bunnell, Devon Cataldi, Yannik Glaser, Thomas K. Wolfgruber, Steven Heymsfield, Alan B. Zonderman, Thomas L. Kelly, Peter Sadowski, John A. Shepherd

arxiv logo•preprint•Aug 13 2025
Total-body dual X-ray absorptiometry (TBDXA) imaging is a relatively low-cost whole-body imaging modality, widely used for body composition assessment. We develop and validate a deep learning method for automatic fiducial point placement on TBDXA scans using 1,683 manually-annotated TBDXA scans. The method achieves 99.5% percentage correct keypoints in an external testing dataset. To demonstrate the value for shape and appearance modeling (SAM), our method is used to place keypoints on 35,928 scans for five different TBDXA imaging modes, then associations with health markers are tested in two cohorts not used for SAM model generation using two-sample Kolmogorov-Smirnov tests. SAM feature distributions associated with health biomarkers are shown to corroborate existing evidence and generate new hypotheses on body composition and shape's relationship to various frailty, metabolic, inflammation, and cardiometabolic health markers. Evaluation scripts, model weights, automatic point file generation code, and triangulation files are available at https://github.com/hawaii-ai/dxa-pointplacement.
X-RayDetectionWhole BodyMethodologyIn SilicoAcademic LabOpen Code

NEURAL: Attention-Guided Pruning for Unified Multimodal Resource-Constrained Clinical Evaluation

Devvrat Joshi, Islem Rekik

arxiv logo•preprint•Aug 13 2025
The rapid growth of multimodal medical imaging data presents significant storage and transmission challenges, particularly in resource-constrained clinical settings. We propose NEURAL, a novel framework that addresses this by using semantics-guided data compression. Our approach repurposes cross-attention scores between the image and its radiological report from a fine-tuned generative vision-language model to structurally prune chest X-rays, preserving only diagnostically critical regions. This process transforms the image into a highly compressed, graph representation. This unified graph-based representation fuses the pruned visual graph with a knowledge graph derived from the clinical report, creating a universal data structure that simplifies downstream modeling. Validated on the MIMIC-CXR and CheXpert Plus dataset for pneumonia detection, NEURAL achieves a 93.4-97.7\% reduction in image data size while maintaining a high diagnostic performance of 0.88-0.95 AUC, outperforming other baseline models that use uncompressed data. By creating a persistent, task-agnostic data asset, NEURAL resolves the trade-off between data size and clinical utility, enabling efficient workflows and teleradiology without sacrificing performance. Our NEURAL code is available at https://github.com/basiralab/NEURAL.
X-RayDetectionChestMethodologyIn SilicoAcademic LabOpen Code

Safeguarding Generative AI Applications in Preclinical Imaging through Hybrid Anomaly Detection

Jakub Binda, Valentina Paneta, Vasileios Eleftheriadis, Hongkyou Chung, Panagiotis Papadimitroulas, Neo Christopher Chung

arxiv logo•preprint•Aug 11 2025
Generative AI holds great potentials to automate and enhance data synthesis in nuclear medicine. However, the high-stakes nature of biomedical imaging necessitates robust mechanisms to detect and manage unexpected or erroneous model behavior. We introduce development and implementation of a hybrid anomaly detection framework to safeguard GenAI models in BIOEMTECH's eyes(TM) systems. Two applications are demonstrated: Pose2Xray, which generates synthetic X-rays from photographic mouse images, and DosimetrEYE, which estimates 3D radiation dose maps from 2D SPECT/CT scans. In both cases, our outlier detection (OD) enhances reliability, reduces manual oversight, and supports real-time quality control. This approach strengthens the industrial viability of GenAI in preclinical settings by increasing robustness, scalability, and regulatory compliance.
Mixed ModalityDetectionWhole BodyMethodologyPrototypeStartupGenAI

A Novel Multimodal Framework for Early Detection of Alzheimers Disease Using Deep Learning

Tatwadarshi P Nagarhalli, Sanket Patil, Vishal Pande, Uday Aswalekar, Prafulla Patil

arxiv logo•preprint•Aug 5 2025
Alzheimers Disease (AD) is a progressive neurodegenerative disorder that poses significant challenges in its early diagnosis, often leading to delayed treatment and poorer outcomes for patients. Traditional diagnostic methods, typically reliant on single data modalities, fall short of capturing the multifaceted nature of the disease. In this paper, we propose a novel multimodal framework for the early detection of AD that integrates data from three primary sources: MRI imaging, cognitive assessments, and biomarkers. This framework employs Convolutional Neural Networks (CNN) for analyzing MRI images and Long Short-Term Memory (LSTM) networks for processing cognitive and biomarker data. The system enhances diagnostic accuracy and reliability by aggregating results from these distinct modalities using advanced techniques like weighted averaging, even in incomplete data. The multimodal approach not only improves the robustness of the detection process but also enables the identification of AD at its earliest stages, offering a significant advantage over conventional methods. The integration of biomarkers and cognitive tests is particularly crucial, as these can detect Alzheimer's long before the onset of clinical symptoms, thereby facilitating earlier intervention and potentially altering the course of the disease. This research demonstrates that the proposed framework has the potential to revolutionize the early detection of AD, paving the way for more timely and effective treatments
MRIDetectionNeurologicalMethodologyIn Silico

Scaling Artificial Intelligence for Prostate Cancer Detection on MRI towards Population-Based Screening and Primary Diagnosis in a Global, Multiethnic Population (Study Protocol)

Anindo Saha, Joeran S. Bosma, Jasper J. Twilt, Alexander B. C. D. Ng, Aqua Asif, Kirti Magudia, Peder Larson, Qinglin Xie, Xiaodong Zhang, Chi Pham Minh, Samuel N. Gitau, Ivo G. Schoots, Martijn F. Boomsma, Renato Cuocolo, Nikolaos Papanikolaou, Daniele Regge, Derya Yakar, Mattijs Elschot, Jeroen Veltman, Baris Turkbey, Nancy A. Obuchowski, Jurgen J. Fütterer, Anwar R. Padhani, Hashim U. Ahmed, Tobias Nordström, Martin Eklund, Veeru Kasivisvanathan, Maarten de Rooij, Henkjan Huisman

arxiv logo•preprint•Aug 4 2025
In this intercontinental, confirmatory study, we include a retrospective cohort of 22,481 MRI examinations (21,288 patients; 46 cities in 22 countries) to train and externally validate the PI-CAI-2B model, i.e., an efficient, next-generation iteration of the state-of-the-art AI system that was developed for detecting Gleason grade group $\geq$2 prostate cancer on MRI during the PI-CAI study. Of these examinations, 20,471 cases (19,278 patients; 26 cities in 14 countries) from two EU Horizon projects (ProCAncer-I, COMFORT) and 12 independent centers based in Europe, North America, Asia and Africa, are used for training and internal testing. Additionally, 2010 cases (2010 patients; 20 external cities in 12 countries) from population-based screening (STHLM3-MRI, IP1-PROSTAGRAM trials) and primary diagnostic settings (PRIME trial) based in Europe, North and South Americas, Asia and Australia, are used for external testing. Primary endpoint is the proportion of AI-based assessments in agreement with the standard of care diagnoses (i.e., clinical assessments made by expert uropathologists on histopathology, if available, or at least two expert urogenital radiologists in consensus; with access to patient history and peer consultation) in the detection of Gleason grade group $\geq$2 prostate cancer within the external testing cohorts. Our statistical analysis plan is prespecified with a hypothesis of diagnostic interchangeability to the standard of care at the PI-RADS $\geq$3 (primary diagnosis) or $\geq$4 (screening) cut-off, considering an absolute margin of 0.05 and reader estimates derived from the PI-CAI observer study (62 radiologists reading 400 cases). Secondary measures comprise the area under the receiver operating characteristic curve (AUROC) of the AI system stratified by imaging quality, patient age and patient ethnicity to identify underlying biases (if any).
MRIDetectionAbdominalRetrospective ClinicalIn SilicoConsortiumBenchmark SOTAOpen DatasetEthics

Medical Image De-Identification Benchmark Challenge

Linmin Pei, Granger Sutton, Michael Rutherford, Ulrike Wagner, Tracy Nolan, Kirk Smith, Phillip Farmer, Peter Gu, Ambar Rana, Kailing Chen, Thomas Ferleman, Brian Park, Ye Wu, Jordan Kojouharov, Gargi Singh, Jon Lemon, Tyler Willis, Milos Vukadinovic, Grant Duffy, Bryan He, David Ouyang, Marco Pereanez, Daniel Samber, Derek A. Smith, Christopher Cannistraci, Zahi Fayad, David S. Mendelson, Michele Bufano, Elmar Kotter, Hamideh Haghiri, Rajesh Baidya, Stefan Dvoretskii, Klaus H. Maier-Hein, Marco Nolden, Christopher Ablett, Silvia Siggillino, Sandeep Kaushik, Hongzhu Jiang, Sihan Xie, Zhiyu Wan, Alex Michie, Simon J Doran, Angeline Aurelia Waly, Felix A. Nathaniel Liang, Humam Arshad Mustagfirin, Michelle Grace Felicia, Kuo Po Chih, Rahul Krish, Ghulam Rasool, Nidhal Bouaynaya, Nikolas Koutsoubis, Kyle Naddeo, Kartik Pandit, Tony O'Sullivan, Raj Krish, Qinyan Pan, Scott Gustafson, Benjamin Kopchick, Laura Opsahl-Ong, Andrea Olvera-Morales, Jonathan Pinney, Kathryn Johnson, Theresa Do, Juergen Klenk, Maria Diaz, Arti Singh, Rong Chai, David A. Clunie, Fred Prior, Keyvan Farahani

arxiv logo•preprint•Jul 31 2025
The de-identification (deID) of protected health information (PHI) and personally identifiable information (PII) is a fundamental requirement for sharing medical images, particularly through public repositories, to ensure compliance with patient privacy laws. In addition, preservation of non-PHI metadata to inform and enable downstream development of imaging artificial intelligence (AI) is an important consideration in biomedical research. The goal of MIDI-B was to provide a standardized platform for benchmarking of DICOM image deID tools based on a set of rules conformant to the HIPAA Safe Harbor regulation, the DICOM Attribute Confidentiality Profiles, and best practices in preservation of research-critical metadata, as defined by The Cancer Imaging Archive (TCIA). The challenge employed a large, diverse, multi-center, and multi-modality set of real de-identified radiology images with synthetic PHI/PII inserted. The MIDI-B Challenge consisted of three phases: training, validation, and test. Eighty individuals registered for the challenge. In the training phase, we encouraged participants to tune their algorithms using their in-house or public data. The validation and test phases utilized the DICOM images containing synthetic identifiers (of 216 and 322 subjects, respectively). Ten teams successfully completed the test phase of the challenge. To measure success of a rule-based approach to image deID, scores were computed as the percentage of correct actions from the total number of required actions. The scores ranged from 97.91% to 99.93%. Participants employed a variety of open-source and proprietary tools with customized configurations, large language models, and optical character recognition (OCR). In this paper we provide a comprehensive report on the MIDI-B Challenge's design, implementation, results, and lessons learned.
Mixed ModalityDetectionWhole BodyRetrospective ClinicalIn SilicoConsortiumOpen DatasetReproducibility

A Modified VGG19-Based Framework for Accurate and Interpretable Real-Time Bone Fracture Detection

Md. Ehsanul Haque, Abrar Fahim, Shamik Dey, Syoda Anamika Jahan, S. M. Jahidul Islam, Sakib Rokoni, Md Sakib Morshed

arxiv logo•preprint•Jul 31 2025
Early and accurate detection of the bone fracture is paramount to initiating treatment as early as possible and avoiding any delay in patient treatment and outcomes. Interpretation of X-ray image is a time consuming and error prone task, especially when resources for such interpretation are limited by lack of radiology expertise. Additionally, deep learning approaches used currently, typically suffer from misclassifications and lack interpretable explanations to clinical use. In order to overcome these challenges, we propose an automated framework of bone fracture detection using a VGG-19 model modified to our needs. It incorporates sophisticated preprocessing techniques that include Contrast Limited Adaptive Histogram Equalization (CLAHE), Otsu's thresholding, and Canny edge detection, among others, to enhance image clarity as well as to facilitate the feature extraction. Therefore, we use Grad-CAM, an Explainable AI method that can generate visual heatmaps of the model's decision making process, as a type of model interpretability, for clinicians to understand the model's decision making process. It encourages trust and helps in further clinical validation. It is deployed in a real time web application, where healthcare professionals can upload X-ray images and get the diagnostic feedback within 0.5 seconds. The performance of our modified VGG-19 model attains 99.78\% classification accuracy and AUC score of 1.00, making it exceptionally good. The framework provides a reliable, fast, and interpretable solution for bone fracture detection that reasons more efficiently for diagnoses and better patient care.
X-RayDetectionMusculoskeletalMethodologyIn SilicoGenAI

DICOM De-Identification via Hybrid AI and Rule-Based Framework for Scalable, Uncertainty-Aware Redaction

Kyle Naddeo, Nikolas Koutsoubis, Rahul Krish, Ghulam Rasool, Nidhal Bouaynaya, Tony OSullivan, Raj Krish

arxiv logo•preprint•Jul 31 2025
Access to medical imaging and associated text data has the potential to drive major advances in healthcare research and patient outcomes. However, the presence of Protected Health Information (PHI) and Personally Identifiable Information (PII) in Digital Imaging and Communications in Medicine (DICOM) files presents a significant barrier to the ethical and secure sharing of imaging datasets. This paper presents a hybrid de-identification framework developed by Impact Business Information Solutions (IBIS) that combines rule-based and AI-driven techniques, and rigorous uncertainty quantification for comprehensive PHI/PII removal from both metadata and pixel data. Our approach begins with a two-tiered rule-based system targeting explicit and inferred metadata elements, further augmented by a large language model (LLM) fine-tuned for Named Entity Recognition (NER), and trained on a suite of synthetic datasets simulating realistic clinical PHI/PII. For pixel data, we employ an uncertainty-aware Faster R-CNN model to localize embedded text, extract candidate PHI via Optical Character Recognition (OCR), and apply the NER pipeline for final redaction. Crucially, uncertainty quantification provides confidence measures for AI-based detections to enhance automation reliability and enable informed human-in-the-loop verification to manage residual risks. This uncertainty-aware deidentification framework achieves robust performance across benchmark datasets and regulatory standards, including DICOM, HIPAA, and TCIA compliance metrics. By combining scalable automation, uncertainty quantification, and rigorous quality assurance, our solution addresses critical challenges in medical data de-identification and supports the secure, ethical, and trustworthy release of imaging data for research.
Mixed ModalityDetectionWhole BodyMethodologyIn SilicoStartupPolicyOpen Code

Out-of-Distribution Detection in Medical Imaging via Diffusion Trajectories

Lemar Abdi, Francisco Caetano, Amaan Valiuddin, Christiaan Viviers, Hamdi Joudeh, Fons van der Sommen

arxiv logo•preprint•Jul 31 2025
In medical imaging, unsupervised out-of-distribution (OOD) detection offers an attractive approach for identifying pathological cases with extremely low incidence rates. In contrast to supervised methods, OOD-based approaches function without labels and are inherently robust to data imbalances. Current generative approaches often rely on likelihood estimation or reconstruction error, but these methods can be computationally expensive, unreliable, and require retraining if the inlier data changes. These limitations hinder their ability to distinguish nominal from anomalous inputs efficiently, consistently, and robustly. We propose a reconstruction-free OOD detection method that leverages the forward diffusion trajectories of a Stein score-based denoising diffusion model (SBDDM). By capturing trajectory curvature via the estimated Stein score, our approach enables accurate anomaly scoring with only five diffusion steps. A single SBDDM pre-trained on a large, semantically aligned medical dataset generalizes effectively across multiple Near-OOD and Far-OOD benchmarks, achieving state-of-the-art performance while drastically reducing computational cost during inference. Compared to existing methods, SBDDM achieves a relative improvement of up to 10.43% and 18.10% for Near-OOD and Far-OOD detection, making it a practical building block for real-time, reliable computer-aided diagnosis.
Mixed ModalityDetectionMethodologyIn SilicoAcademic LabBenchmark SOTA

OCSVM-Guided Representation Learning for Unsupervised Anomaly Detection

Nicolas Pinon, Carole Lartizien

arxiv logo•preprint•Jul 25 2025
Unsupervised anomaly detection (UAD) aims to detect anomalies without labeled data, a necessity in many machine learning applications where anomalous samples are rare or not available. Most state-of-the-art methods fall into two categories: reconstruction-based approaches, which often reconstruct anomalies too well, and decoupled representation learning with density estimators, which can suffer from suboptimal feature spaces. While some recent methods attempt to couple feature learning and anomaly detection, they often rely on surrogate objectives, restrict kernel choices, or introduce approximations that limit their expressiveness and robustness. To address this challenge, we propose a novel method that tightly couples representation learning with an analytically solvable one-class SVM (OCSVM), through a custom loss formulation that directly aligns latent features with the OCSVM decision boundary. The model is evaluated on two tasks: a new benchmark based on MNIST-C, and a challenging brain MRI subtle lesion detection task. Unlike most methods that focus on large, hyperintense lesions at the image level, our approach succeeds to target small, non-hyperintense lesions, while we evaluate voxel-wise metrics, addressing a more clinically relevant scenario. Both experiments evaluate a form of robustness to domain shifts, including corruption types in MNIST-C and scanner/age variations in MRI. Results demonstrate performance and robustness of our proposed mode,highlighting its potential for general UAD and real-world medical imaging applications. The source code is available at https://github.com/Nicolas-Pinon/uad_ocsvm_guided_repr_learning
MRIDetectionNeurologicalMethodologyIn SilicoOpen Code
Page 1 of 5 • 45 results
Show
per page
12345›»

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.